Saudi - Delayed Quote SAR

Dallah Healthcare Company (4004.SR)

Compare
164.20 -3.40 (-2.03%)
At close: June 13 at 3:16 PM GMT+3
Loading Chart for 4004.SR
DELL
  • Previous Close 167.60
  • Open 169.00
  • Bid 164.00 x --
  • Ask 164.20 x --
  • Day's Range 164.00 - 169.00
  • 52 Week Range 131.40 - 194.00
  • Volume 128,869
  • Avg. Volume 73,433
  • Market Cap (intraday) 16.024B
  • Beta (5Y Monthly) 0.20
  • PE Ratio (TTM) 41.68
  • EPS (TTM) 3.94
  • Earnings Date Aug 6, 2024 - Aug 12, 2024
  • Forward Dividend & Yield 2.00 (1.22%)
  • Ex-Dividend Date Jan 17, 2024
  • 1y Target Est 159.30

Dallah Healthcare Company operates as a health care company in the Kingdom of Saudi Arabia. The company engages in operating, managing, equipping, and developing hospitals and healthcare facilities, and medical polyclinics; and the provision of manpower and support services to hospitals and medical centers. It manufactures and distributes pharmaceutical, herbal and cosmetic products, and toiletries. In addition, the company engages in the management and operation of hospitals owned by third parties. Further, it manages private hospitals, medical and diagnostic centers, and an analytical laboratory; and provides medical services. The company was formerly known as Dallah Healthcare Holding Company and changed its name to Dallah Healthcare Company in November 2016. The company was incorporated in 1994 and is based in Riyadh, Saudi Arabia.

www.dallahhealth.com

--

Full Time Employees

December 31

Fiscal Year Ends

Recent News: 4004.SR

Performance Overview: 4004.SR

Trailing total returns as of 6/13/2024, which may include dividends or other distributions. Benchmark is

.

YTD Return

4004.SR
4.03%
Tadawul All Shares Index
3.63%

1-Year Return

4004.SR
1.36%
Tadawul All Shares Index
0.66%

3-Year Return

4004.SR
131.03%
Tadawul All Shares Index
6.51%

5-Year Return

4004.SR
329.32%
Tadawul All Shares Index
26.57%

Compare To: 4004.SR

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: 4004.SR

Valuation Measures

Annual
As of 6/13/2024
  • Market Cap

    16.02B

  • Enterprise Value

    17.73B

  • Trailing P/E

    41.68

  • Forward P/E

    38.17

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    5.33

  • Price/Book (mrq)

    4.82

  • Enterprise Value/Revenue

    5.89

  • Enterprise Value/EBITDA

    26.92

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    12.78%

  • Return on Assets (ttm)

    5.25%

  • Return on Equity (ttm)

    11.78%

  • Revenue (ttm)

    3.01B

  • Net Income Avi to Common (ttm)

    384.76M

  • Diluted EPS (ttm)

    3.94

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    213.64M

  • Total Debt/Equity (mrq)

    53.33%

  • Levered Free Cash Flow (ttm)

    147.29M

Research Analysis: 4004.SR

Company Insights: 4004.SR

Research Reports: 4004.SR

People Also Watch